Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary

被引:0
作者
Aldo Carnevale
Fabio Pellegrino
Alberto Cossu
Anna Maria Ierardi
Gian Carlo Parenti
Gianpaolo Carrafiello
Melchiore Giganti
机构
[1] Arcispedale Sant’Anna,University Radiology Unit, Radiology Department
[2] University of Ferrara,Department of Morphology, Surgery and Experimental Medicine, Radiology Section
[3] University of Milan,Diagnostic and Interventional Radiology Department, ASST Santi Paolo E Carlo, San Paolo Hospital
[4] Ospedale Civile Santa Maria Delle Croci,Department of Diagnostic Imaging of Romagna
来源
Medical Oncology | 2020年 / 37卷
关键词
Benign tumors; Liver; Ablation; Hepatic hemangioma; Hepatocellular adenoma;
D O I
暂无
中图分类号
学科分类号
摘要
With increased use of medical imaging, the incidental detection of benign solid liver tumors has become more frequent. Facing with benign disease, the indications for surgery are still object of discussion in light of the stable natural course of most lesions and obvious drawbacks of any surgical intervention; therefore, in most situations, a conservative approach is recommended, and surgery is mainly reserved for those cases with persistent or worsening symptoms, or who are at risk for complications as malignant transformation. The advent of ablative techniques has widened the range of treatment options available to these patients, presenting as a valid alternative to resection in terms of safety and efficacy in selected cases, particularly in patients who are considered poor surgical candidates and with smaller lesions. This review outlines the role of percutaneous ablative methods for benign solid liver tumors that are encountered in adults, providing a per histology analysis of the existing evidence. The up-to-date strategies for management of the most common benign solid tumors are recapitulated.
引用
收藏
相关论文
共 193 条
[1]  
Belghiti J(2014)Diagnosis and management of solid benign liver lesions Nat Rev Gastroenterol Hepatol 11 737-749
[2]  
Cauchy F(2016)EASL clinical practice guidelines on the management of benign liver tumours J Hepatol 65 386-398
[3]  
Paradis V(2017)Primary benign liver lesions Eur J Radiol Elsevier Ireland Ltd 95 378-398
[4]  
Vilgrain V(2010)Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases HPB (Oxford) 12 509-522
[5]  
Colombo M(2014)Percutaneous hepatic ablation: what needs to be known in 2014 Diagn Interv Imaging 95 665-675
[6]  
Forner A(2010)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 336-341
[7]  
Ijzermans J(2008)Percutaneous radiofrequency ablation of hepatocellular adenoma: Initial experience in 10 patients J Gastroenterol Hepatol 23 e422-e427
[8]  
Paradis V(2011)Safety and efficacy of radiofrequency ablation for hepatocellular adenoma J Vasc Interv Radiol 22 787-793
[9]  
Reeves H(2017)Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour? Eur Radiol 27 1704-1712
[10]  
Vilgrain V(2018)Retrospective single-arm cohort study of patients with hepatocellular adenomas treated with percutaneous thermal ablation Cardiovasc Intervent Radiol 41 935-941